NOS2 and cancer: Several anti-cancer strategies are aimed at bringing elevated S-nitrosylation levels down to physiological levels to suppress the pro-tumor effects of S-nitrosylation with NOS inhibitors, NO scavengers, or denitrosylase mimetics [21,22,23,24,25,26,27].